Pulmonx (LUNG) Income from Continuing Operations (2019 - 2025)
Pulmonx (LUNG) reported Income from Continuing Operations of 13957000.0 for Q3 2025, up 1.38% year-over-year from 13767300.76 in Q3 2024, and up 8.15% quarter-over-quarter from 15196000.0 in Q2 2025.
Pulmonx (LUNG) Income from Continuing Operations (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Income from Continuing Operations data on file, last reported at 13957000.0 in Q3 2025.
- Income from Continuing Operations for Q3 2025 came in at 13957000.0, up 1.38% year-over-year; the trailing twelve-month figure through Sep 2025 was 56741000.0 (up 0.72% YoY), and the FY2024 annual result was 56394000.0, up 7.31% from the prior year.
- Income from Continuing Operations grew to 13957000.0 in Q3 2025 per LUNG's latest filing, from 15196000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 10181000.0 in Q3 2021 and troughed at 16195000.0 in Q2 2023.
- A 5-year average of 14131894.74 and a median of 14172000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2021 and 2024: Income from Continuing Operations slumped 163.76% in 2021, then grew 13.31% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 12997000.0 in 2021, then fell by 9.95% to 14290000.0 in 2022, then gained by 2.65% to 13911000.0 in 2023, then climbed by 5.29% to 13175000.0 in 2024, then decreased by 5.94% to 13957000.0 in 2025.
- Business Quant data shows LUNG's Income from Continuing Operations at 13957000.0 in Q3 2025, 15196000.0 in Q2 2025, and 14413000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.96 Mn |
| Jun 30, 2025 | -15.20 Mn |
| Mar 31, 2025 | -14.41 Mn |
| Dec 31, 2024 | -13.18 Mn |
| Sep 30, 2024 | -14.15 Mn |
| Jun 30, 2024 | -15.34 Mn |
| Mar 31, 2024 | -13.75 Mn |
| Dec 31, 2023 | -13.91 Mn |
| Sep 30, 2023 | -14.94 Mn |
| Jun 30, 2023 | -16.20 Mn |
| Mar 31, 2023 | -15.86 Mn |
| Dec 31, 2022 | -14.29 Mn |
| Sep 30, 2022 | -14.17 Mn |
| Jun 30, 2022 | -14.64 Mn |
| Mar 31, 2022 | -15.86 Mn |
| Dec 31, 2021 | -13.00 Mn |
| Sep 30, 2021 | -10.18 Mn |
| Jun 30, 2021 | -12.96 Mn |
| Mar 31, 2021 | -12.51 Mn |
| Dec 31, 2020 | -9.29 Mn |